Articles:

H Hinrichsen, A Halabi, and W Kirch

Clinical aspects of cardiovascular effects of H2-receptor antagonists
J Clin Pharmacol 1995 35: 107. [Abstract] [PDF]  

AJ Ingenito and WR Wooles

Survey results of POPS use in United States and Canadian schools of medicine and pharmacy
J Clin Pharmacol 1995 35: 117. [Abstract] [PDF]  

YW Lam, MW Jann, WH Chang, HS Yu, SK Lin, H Chen, and CM Davis

Intra- and interethnic variability in reduced haloperidol to haloperidol ratios
J Clin Pharmacol 1995 35: 128. [Abstract] [PDF]  

JF Pritchard, GR Matzke, JA Opsahl, CE Halstenson, and RK Nayak

Effects of hemodialysis on plasma protein binding of bepridil
J Clin Pharmacol 1995 35: 137. [Abstract] [PDF]  

J Triscari, D O'Donnell, M Zinny, and HY Pan

Gastrointestinal absorption of pravastatin in healthy subjects
J Clin Pharmacol 1995 35: 142. [Abstract] [PDF]  

NF Ford, KC Lasseter, DR Van Harken, JL Hammett, R Raymond, and J Manning

Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment
J Clin Pharmacol 1995 35: 145. [Abstract] [PDF]  

T Kosoglou, DJ Kazierad, JJ Schentag, JE Patrick, L Heimark, E Radwanski, D Christopher, BE Flannery, and MB Affrime

Effect of food on the oral bioavailability of isosorbide-5-mononitrate administered as an extended-release tablet
J Clin Pharmacol 1995 35: 151. [Abstract] [PDF]  

SK Gupta, MA Southam, and SS Hwang

Evaluation of diurnal variation in fentanyl clearance
J Clin Pharmacol 1995 35: 159. [Abstract] [PDF]  

SA Waldman and J Morganroth

Effects of food on the bioequivalence of different verapamil sustained-release formulations
J Clin Pharmacol 1995 35: 163. [Abstract] [PDF]  

MJ Goldberg, JF Collins, HM Rowe, and BJ Cerimele

Local and systemic phentolamine antagonism of norepinephrine-induced hand vein constriction
J Clin Pharmacol 1995 35: 170. [Abstract] [PDF]  

L Poggesi, G Bisi, G La Cava, R Sciagra, A Del Rosso, and G Masotti

Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol
J Clin Pharmacol 1995 35: 176. [Abstract] [PDF]  

WH Frishman, JF Burris, WJ Mroczek, MR Weir, D Alemayehu, JS Simon, SY Chen, and BS Bryzinski

First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension
J Clin Pharmacol 1995 35: 182. [Abstract] [PDF]  

NR Cutler, J Eff, G Fromell, EP Brass, S Archer, SG Chrysant, and R Fiddes

Dose-ranging study of a new, once-daily diltiazem formulation for patients with stable angina
J Clin Pharmacol 1995 35: 189. [Abstract] [PDF]  

DJ Kazierad, GJ Wojcik, DE Nix, AL Goldfarb, and JJ Schentag

The effect of verapamil on the nephrotoxic potential of gentamicin as measured by urinary enzyme excretion in healthy volunteers
J Clin Pharmacol 1995 35: 196. [Abstract] [PDF]  

SK Gupta, RL Kunka, A Metz, T Lloyd, G Rudolph, and JM Perel

Effect of alosetron (a new 5-HT3 receptor antagonist) on the pharmacokinetics of haloperidol in schizophrenic patients
J Clin Pharmacol 1995 35: 202. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.